COCA Now Messages
COCA provides subscribers information on current health issues and emerging threats. Designed to be timely and concise, the COCA Now email message will inform clinicians of new CDC resources and guidance related to emergency preparedness and response. COCA Now emails will be sent as soon as possible after CDC publishes new content, ensuring clinicians are kept up to date.
2024 COCA Now Messages
- COCA Now: February 12, 2024: CDC Urges Mpox Vaccination for Those Eligible Given Continued U.S. Mpox Cases
- COCA Now: January 26, 2024: Reminder of Recommendations for Seasonal Administration of Maternal RSV Vaccine
- COCA Now: January 25, 2024: Stay Alert for Measles Cases
- COCA Now: January 22, 2024: Information on Respiratory Syncytial Virus (RSV) Vaccine Administration Errors in Young Children and Pregnant People
- COCA Now: January 5, 2024: Updated Guidance for Healthcare Providers on Increased Supply of Nirsevimab to Protect Young Children from Severe Respiratory Syncytial Virus (RSV) during the 2023–2024 Respiratory Virus Season
- COCA Now: January 5, 2024: Update on High Blood Lead Levels in Children Consuming Recalled Cinnamon Applesauce Pouches and Potential Chromium Exposure
2023 COCA Now Messages
- COCA Now: December 18, 2023: Flu Vaccination during Pregnancy Decreases Flu Hospitalizations and Emergency Department Visits in Infants after Birth
- COCA Now: August 25, 2023: Antifungal-resistant Ringworm Infections
- COCA Now: July 12, 2023: NARMS Data Now Available on Sanford Guide
- COCA Now: June 9, 2023: Tecovirimat (TPOXX) Available Through STOMP Trial
- COCA Now: June 07, 2023: Save a Life—Updated CDC Training on Recognizing and Treating Rocky Mountain Spotted Fever
- COCA Now: May 18, 2023: New Study about Epidemiology of Salmonellosis Among Infants
- COCA Now: March 09, 2023: CDC Releases Interim Clinical Treatment Considerations for Severe Manifestations of Mpox
- COCA Now: February 02, 2023: CDC Launches Website to Help Consumers Find Free COVID-19 Testing Sites
2022 COCA Now Messages
- COCA Now: December 09, 2022: Updated HHS Mpox Vaccination Program Provider Agreement
- COCA Now: December 05, 2022: Travelers Returning to the United States with Cholera – Information and CDC Guidance for Healthcare Providers
- COCA Now: October 20, 2022: Travel-associated Multidrug-Resistant Salmonella Newport Infections
- COCA Now: September 21, 2022: Interim Tecovirimat (TPOXX) Guidance and Clinical Considerations for Pain Management of Mpox
- COCA Now: September 19, 2022: Recommendations to Prevent Occupationally-acquired Mpox Infection in Healthcare Personnel
- COCA Now: August 30, 2022: Clinical Considerations for Dengue Virus Infection
- COCA Now: August 10, 2022: FDA Authorizes Emergency Use of Mpox JYNNEOS Vaccine
- COCA Now: July 27, 2022: Clinical Considerations for Mpox in Children and Adolescents
- COCA Now: July 22, 2022: New Streamlined Process to Provide Tecovirimat (TPOXX) for Treatment of Mpox
- COCA Now: July 19, 2022: Steps for Clinicians to Order Medication to Treat Mpox
- COCA Now: July 18, 2022: Sonic Healthcare USA Begins Mpox Testing, Increasing Nationwide Testing Capacity
- COCA Now: July 14, 2022: Quest Diagnostics Begins Mpox Testing, Increasing Nationwide Testing Capacity
- COCA Now: July 14, 2022: Aegis Sciences Begins Mpox Testing
- COCA Now: July 12, 2022: Mayo Clinic Laboratories Begins Mpox Testing
- COCA Now: July 6, 2022: Labcorp Begins Mpox Testing Today, Doubling Nationwide Testing Capacity
- COCA Now: July 5, 2022: CDC Recommends Moderna COVID-19 Vaccine (Spikevax) for Children and Adolescents Ages 6 through 17 Years
- COCA Now: April 4, 2022: New COVID-19 Test to Treat Initiative and Locator Tool
- COCA Now: March 25, 2022: New CDC COVID-19 Quarantine and Isolation (Q&I) Calculator
- COCA Now: February 24, 2022: Updated List of High-Risk Medical Conditions for Severe COVID-19 Outcomes
- COCA Now: February 1, 2022: Ivermectin Products are Not Approved by FDA to Prevent or Treat COVID-19
- COCA Now: January 31, 2022: How to Talk with Parents and Caregivers about COVID-19 Vaccination
2021 COCA Now Messages
- December 22, 2021: CDC Encourages Healthcare Providers to Recommend COVID-19 Self-testing Before Holiday Gatherings
- November 2, 2021: CDC Updates Blood Lead Reference Value to 3.5 µg/dL
- September 10, 2021: COCA NOW Clarification COCA Memo: Monoclonal Antibodies Bamlanivimab and Etesevimab May Be Less Effective for Treating Cases of COVID-19 Caused by SARS-CoV-2 Variants
- July 15, 2021: A Snapshot of Work by the COVID-19 Public Health Response
- June 25, 2021: CDC Introduces COVID-19 Viral Testing Online Tool
- March 08, 2021: CDC Infection Prevention and Control Guidance for Identifying and Managing Patients with Possible and Confirmed Ebola Virus Disease
- February 17, 2021: MMWR and JAMA Updates: SARS-CoV-2 Variants
- February 12, 2021: New Botulism Treatment Resources for Healthcare Professionals
- January 05, 2021: Strategies for Optimizing PPE Supplies during Shortages
2020 COCA Now Messages
- December 09: Similarities in Symptoms of SARS-CoV-2 Infection and Carbon Monoxide (CO) Poisoning
- November 16: Scientific Brief: Community Use of Cloth Masks to Control Spread of SARS-CoV-2
- November 2: Two MMWR Updates: Pregnant Women and COVID-19
- October 26: COVID-19–Associated Hospitalizations among Health Care Personnel
- August 10: COVID-19 Laboratory Reporting Requirements
- May 7: New YouTube Video with Guidance for Certifying Deaths Due to COVID-19
- February 24: Sign-up to Receive CDC’s New COVID-19 “What’s New” Weekly Update
- Shipping of CDC 2019 Novel Coronavirus Diagnostic Test Kits Begins
- MMWR Updates: Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak; and Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020